Tower Research Capital LLC (TRC) - APTEVO THERAPEUTICS INC ownership

APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 24 filers reported holding APTEVO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of APTEVO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,453
+104.7%
13,495
+805.7%
0.00%
Q2 2023$2,1751,490
+1218.6%
0.00%
Q4 2022$0
-100.0%
113
-96.0%
0.00%
Q3 2022$9,000
-50.0%
2,808
+135.2%
0.00%
Q3 2021$18,000
+350.0%
1,194
+752.9%
0.00%
Q1 2021$4,000
-55.6%
140
-42.1%
0.00%
Q4 2020$9,000
-55.0%
242
-90.1%
0.00%
-100.0%
Q2 2020$20,000
+1900.0%
2,446
+761.3%
0.00%
Q1 2020$1,0002840.00%
Other shareholders
APTEVO THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,760,000$39,477,0007.86%
RTW INVESTMENTS, LP 281,402$6,312,0000.10%
KENNEDY CAPITAL MANAGEMENT LLC 187,995$4,217,0000.09%
Anson Funds Management LP 35,587$798,0000.08%
Alyeska Investment Group, L.P. 139,172$3,122,0000.04%
Dynamic Technology Lab Private Ltd 14,022$315,0000.03%
JBF Capital, Inc. 3,907$88,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 15,350$344,0000.01%
Renaissance Technologies 159,923$3,587,0000.00%
QS Investors, LLC 15,650$352,0000.00%
View complete list of APTEVO THERAPEUTICS INC shareholders